Amrollahi Narjes, Karimi Rahele, Shariati Faezeh
Dental Research Center, Department of Pediatric Dentistry, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Saudi Dent J. 2024 Aug;36(8):1058-1065. doi: 10.1016/j.sdentj.2024.06.008. Epub 2024 Jun 6.
Various dressing materials have been evaluated for pulpotomy of primary teeth. However, an ideal pulp dressing material has not been identified yet. This systematic review investigated the effectiveness of TheraCal compared to Formocresol in pulpotomy of primary teeth.
This research was conducted in the form of a secondary study, with a systematic search of texts until 2023 in Scopus, Web of Science, PubMed and Google Scholar databases. The articles were selected based on the inclusion and exclusion criteria and, finally the search results were reported in the PRISMA chart. The quality of the studies was evaluated based on the NIH checklist. The extracted information was entered into Stata17 software. Heterogeneity was evaluated using Cochran's chi-square test and I statistics. Egger's tests were used to detect publication bias
After removing duplicate articles and articles that did not meet the inclusion criteria, 4 studies were selected for qualitative analysis. The odds' ratio of success rate between Formocresol and TheraCal pulpotomy for absence of the pain, abscess, Mobility, internal root resorption and bone radiolucency was obtained 1.12 (95 % CI: 0.32, 3.85, P = 0.86), 0.47 (95 % CI: 0.1, 2.14, P = 0.33), 0.82 (95 % CI: 0.21, 3.21, P = 0.78), 0.89 (95 % CI: 0.3, 2.67, P = 0.84), and 1.96 (95 % CI: 0.68, 5.62, P = 0.21) respectively.
The study results revealed that there was no significant difference in clinical and radiographic success between pulpotomy with TheraCal and Formocresol.
已对多种用于乳牙牙髓切断术的敷料材料进行了评估。然而,尚未确定理想的牙髓敷料材料。本系统评价研究了与甲醛甲酚相比,TheraCal在乳牙牙髓切断术中的有效性。
本研究以二次研究的形式进行,在Scopus、Web of Science、PubMed和谷歌学术数据库中系统检索截至2023年的文献。根据纳入和排除标准选择文章,最后在PRISMA图中报告检索结果。根据美国国立卫生研究院(NIH)清单评估研究质量。将提取的信息录入Stata17软件。使用Cochran卡方检验和I统计量评估异质性。使用Egger检验检测发表偏倚。
在去除重复文章和不符合纳入标准的文章后,选择了4项研究进行定性分析。甲醛甲酚和TheraCal牙髓切断术在无疼痛、脓肿、松动、牙根内吸收和骨透射区方面成功率的比值比分别为1.12(95%可信区间:0.32,3.85,P = 0.86)、0.47(95%可信区间:0.1,2.14,P = 0.33)、0.82(95%可信区间:0.21,3.21,P = 0.78)、0.89(95%可信区间:0.3,2.67,P = 0.84)和1.96(95%可信区间:0.68,5.62,P = 0.21)。
研究结果表明,TheraCal和甲醛甲酚牙髓切断术在临床和影像学成功率方面无显著差异。